(Total Views: 502)
Posted On: 06/12/2022 3:06:57 PM
Post# of 154857
I can’t recall. cT1 or PDFF. One of those used to be measured by a biopsy and now by MRI. Either way, wouldn’t (or won’t rather) our P3 trial be expensive and take awhile? Especially if we do as you suggested in an earlier post, 1500 patients including 500 in placebo arm.
I guess what I’m wondering is what our p3 looks like really dialed in to things like haplotype, dose escalation, and how expensive and how long will it take. Too much for you to answer. A lot and too long, is sufficient.
What I’m really asking I guess is how will cD1 and PDFF levels be obtained?
TIA for any education in that regard. I think I knew at one point.
I guess what I’m wondering is what our p3 looks like really dialed in to things like haplotype, dose escalation, and how expensive and how long will it take. Too much for you to answer. A lot and too long, is sufficient.
What I’m really asking I guess is how will cD1 and PDFF levels be obtained?
TIA for any education in that regard. I think I knew at one point.
(1)
(0)
